Response to: ‘Medications associated with fracture risk in patients with rheumatoid arthritis’ by Chen et al

We appreciate the interest shown by Dr Chen1 concerning our recent study on medications associated with fracture risk in patients with rheumatoid arthritis (RA).2 We would like to clarify some issues Chen et al indicated. First, we agree that osteoporotic fractures are more common in patients with inflammatory diseases. However, in our study, we excluded all patients with prevalent fractures to estimate the...